In a suddenly busy week for all manner of financial services corporate issuers in the Australian dollar markets, some notable transactions were launched or priced yesterday.Leading off, Challenger yesterday announced its intention to issue A$250 million or more of Challenger Capital Notes.The notes will be Additional Tier 1 capital for Challenger Life Company. The announcement was made in conjunction with a A$250 million underwritten institutional share placement, completed yesterday, along with the announcement of a A$30 million share purchase plan for retail investors. The proceeds of the share placements will also go to Challenger Life Company as common equity tier 1 capital. A prospectus for the capital notes will be lodged with the ASX shortly.The outcome of ME Bank's Tier 2 capital raising was also outlined yesterday. The bank raised A$300 million, priced at 270 basis points over the 90 day bank bill rate. The bank had been seeking at least A$100 million at an indicative spread of 280 bps overYesterday also saw UBS Australia Branch price a A$1.1 billion benchmark five-year dual-tranche senior unsecured medium term note transaction. The two tranches were, respectively: $400 million fixed rate notes, paying a semi-annual coupon of 4.00 per cent, sold at an issue price of 99.496 to yield 4.1125 per cent semi-annually. This equates to 95 bps over the semi-quarterly asset swap. $700 million floating rate notes, paying a coupon of 95 bps over the 3-month BBSW, priced at par.The local branch of the Swiss bank is rated A2 by Moodys, A by S&P and A by Fitch. The Joint Lead Managers are ANZ, CBA, NAB, UBS Investment Bank and Westpac Institutional Bank. The settlement date is 27 August.(Additional reporting by Bernard Kellerman)